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Abstract
 
The expression of leukocyte and endothelial cell adhesion molecules (CAMs) is essential for the
emigration of leukocytes during an inflammatory response. The importance of the inflamma-
tory response in the development of atherosclerosis is indicated by the increased expression of
adhesion molecules, proinflammatory cytokines, and growth factors in lesions and lesion-prone
areas and by protection in mice deficient in various aspects of the inflammatory response. We
have quantitated the effect of deficiency for intercellular adhesion molecule (ICAM)-1, P-selectin,
or E-selectin on atherosclerotic lesion formation at 20 wk of age in apolipoprotein (apo) E
 
2
 
/
 
2
 
(deficient) mice fed a normal chow diet. All mice were apo E
 
2
 
/
 
2
 
 and CAM
 
1
 
/
 
1
 
 or CAM
 
2
 
/
 
2
 
littermates, and no differences were found in body weight or cholesterol levels among the var-
ious genotypes during the study. ICAM-1
 
2
 
/
 
2
 
 mice had significantly less lesion area than their
ICAM-1
 
1
 
/
 
1
 
 littermates: 4.08 
 
6
 
 0.70 mm
 
2
 
 for 
 
2
 
/
 
2
 
 males vs. 5.87 
 
6
 
 0.66 mm
 
2
 
 for 
 
1
 
/
 
1
 
 males,
and 3.95 
 
6
 
 0.65 mm
 
2
 
 for 
 
2
 
/
 
2
 
 females vs. 5.59 
 
6
 
 1.131 mm
 
2
 
 for 
 
1
 
/
 
1
 
 females, combined
 
 P 
 
,
 
0.0001. An even greater reduction in lesion area was observed in P-selectin
 
2
 
/
 
2
 
 mice: 3.06 
 
6
 
1.04 mm
 
2
 
 for 
 
2
 
/
 
2
 
 males vs. 5.09 
 
6
 
 1.22 mm
 
2
 
 for 
 
1
 
/
 
1
 
 males, and 2.85 
 
6
 
 1.26 mm
 
2
 
 for 
 
2
 
/
 
2
 
females compared with 5.60 
 
6
 
 1.19 mm
 
2
 
 for 
 
1
 
/
 
1
 
 females, combined
 
 P 
 
, 
 
0.001. The reduc-
tion in lesion area for the E-selectin null mice, although less than that seen for ICAM-1 or
P-selectin, was still significant (4.54 
 
6
 
 2.14 mm
 
2
 
 for 
 
2
 
/
 
2
 
 males vs. 5.92 
 
6
 
 0.63 mm
 
2
 
 for 
 
1
 
/
 
1
 
males, and 4.38 
 
6
 
 0.85 mm
 
2
 
 for 
 
2
 
/
 
2
 
 females compared with 5.94 
 
6
 
 1.44 mm
 
2
 
 for 
 
1
 
/
 
1
 
 fe-
males, combined
 
 P 
 
, 
 
0.01). These results, coupled with the closely controlled genetics of this
study, indicate that reductions in the expression of P-selectin, ICAM-1, or E-selectin provide
direct protection from atherosclerotic lesion formation in this model.
Key words: E-selectin • cell adhesion molecules • aorta • cholesterol • intercellular adhesion 
molecule-1
 
Introduction
 
The development of atherosclerosis is influenced by many
genetic and environmental factors. These include diet, smok-
ing, and variations in lipid metabolism genes (1). Evidence
also suggests a role for the inflammatory response in the
pathogenesis of atherosclerosis with the adhesion of circulat-
ing leukocytes, especially monocytes, to the endothelium at
sites of injury (2, 3). Leukocyte adhesion and emigration into
the subendothelial space, in response to chemoattractants and
other activating molecules, is mediated by leukocyte and en-
dothelial cell adhesion molecules (CAMs). After migration
into particular lesion-prone areas of the arterial vasculature,
some monocytes ingest lipids and become foam cells, initiating
a complex chain of events ending in lesion development (2, 3).
Leukocyte emigration from the vasculature occurs in
several steps regulated by distinct adhesion molecules. Leu-
kocytes first undergo E-, L-, and P-selectin–mediated roll-
ing along the endothelial surface, followed by firm attach-
ment involving the 
 
b
 
1
 
- and 
 
b
 
2
 
-integrins and Ig adhesion
superfamily members such as intercellular adhesion mole-
cule (ICAM)-1 and vascular (V)CAM-1 (4). Several of these
molecules, including ICAM-1, VCAM-1, E-selectin, and
P-selectin, show increased expression in atherosclerotic le-
sions (5–9). This includes studies in mice, rabbits, and hu-
mans and also includes evidence that a high-fat diet increases
expression of various CAMs.
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Because of the major potential for genetic manipulation
in the mouse (10), a variety of strategies including trans-
genic overexpression, inactivating mutations induced by
homologous recombination, and blocking mAbs have been
used to study the relationships between leukocyte and en-
dothelial CAMs and other aspects of the inflammatory pro-
cess associated with atherosclerosis as reviewed elsewhere
(11). Antibodies to 
 
a
 
4
 
-integrin and ICAM-1 have been
used in apolipoprotein (apo) E
 
2
 
/
 
2
 
 (deficient) mice to dem-
onstrate reduction in recruitment of monocytes to athero-
sclerotic plaques (12). A blocking antibody to CD40 ligand
decreased atherosclerosis in low density lipoprotein recep-
tor (LDLR)
 
2
 
/
 
2
 
 mice fed a high-cholesterol diet, with a
demonstrated effect on both macrophages and lymphocytes
(13). Osteopetrotic mice lacking macrophage colony-simu-
lating factor were protected against atherosclerosis under a
variety of conditions (14, 15). In apo E
 
2
 
/
 
2
 
 mice fed a high-
fat diet, deficiency for the monocyte chemoattractant pro-
tein 1 receptor, CCR2, reduced lesions (16).
Various studies have directly assessed mice lacking ex-
pression of one or more CAMs for the effect on atheroscle-
rosis. In a study using C57BL/6 mice fed a high-fat diet, a
50–75% reduction in atherosclerotic fatty streaks was found
in mice deficient for ICAM-1, P-selectin, or CD18 (17). In
studies of mice deficient for P-selectin or both P- and E-selec-
tin conducted with LDLR
 
2
 
/
 
2
 
 mice, a modest effect was
seen in male but not female mice lacking P-selectin, whereas
a more substantial reduction in lesions was seen in the P-
and E-selectin double-deficient mice (18, 19). The P- and
E-selectin double-mutant mice develop inflammatory skin
disease, which might influence lesion development (20, 21),
and the studies of C57BL/6 and LDLR
 
2
 
/
 
2
 
 mice involved
use of a diet high in cholesterol and cholic acid, the latter
being an abnormal supplement to the diet that can itself in-
duce a chronic inflammatory state (10). In a study of leuko-
cyte rolling in the carotid arteries of apo E
 
2
 
/
 
2
 
 mice fed a high-
fat diet, blocking mAbs to P-selectin or P-selectin ligand 1
decreased mononuclear cell attachment and rolling, whereas
blocking antibodies to 
 
a
 
4
 
-integrin or VCAM-1 increased
rolling velocities (22).
We wished to study the effect of genetic deficiency for
three individual CAMs (P-selectin, ICAM-1, and E-selectin)
in the apo E
 
2
 
/
 
2
 
 mouse model, in which mice develop spon-
taneous lesions in the arterial vasculature with advanced le-
sions morphologically similar to those seen in humans when
fed a regular chow, high-fat, or high-cholesterol diet (23–25).
Even with a mouse chow diet low in fat and cholesterol, apo
E
 
2
 
/
 
2
 
 mice develop spontaneous atherosclerosis including fi-
broproliferative lesions (24–27) similar to those seen in hu-
mans. In the apo E
 
2
 
/
 
2
 
 mice on normal chow, we observed
substantial reduction in lesions with P-selectin or ICAM-1
deficiency and marginal effects with E-selectin deficiency.
 
Materials and Methods
 
Animals and Diet.
 
The ICAM-1 (28), P-selectin (29), and
E-selectin (20) mice were generated in our laboratory and were
backcrossed onto a C57BL/6 background a minimum of six gen-
erations (N6). Apo E
 
2
 
/
 
2
 
 mice (23) were obtained from The Jack-
son Laboratory and were also backcrossed to C57BL/6 (N6). Mice
of the genotype apo E
 
2
 
/
 
2
 
CAM
 
2
 
/
 
2
 
 were generated by matings
between the two mutant mouse strains and their progeny to pro-
duce three strains of mice double mutant for apo E and ICAM-1,
P-selectin, or E-selectin. See Fig. 1 for the breeding scheme used
to generate the study mice. One double mutant from each group
(apo E
 
2
 
/
 
2
 
CAM
 
2
 
/
 
2
 
) was crossed back to apo E
 
2
 
/
 
2
 
 mice (apo E
 
2
 
/
 
2
 
CAM
 
1
 
/
 
1
 
) to generate apo E
 
2
 
/
 
2
 
CAM
 
1
 
/
 
2
 
 mice. The progeny of
these mice were used in the study. All mice in each adhesion
molecule arm of the study were descendants of the same apo E2/2
CAM2/2 and apo E2/2 grandparental mice. The mice were fed
standard mouse chow (Ralston Purina 5001) containing 6% fat
and 0.0275% cholesterol from weaning until 20 wk of age. Mice
were then killed for lesion analysis. Animals were housed in clean
facilities with sentinel animals that consistently tested negative for
common viral pathogens. Food and water were provided ad libi-
tum, and an alternating 12-h light–dark cycle was maintained.
Cholesterol Determination. Blood was collected from the retro-
orbital venus plexus of anesthetized mice after fasting overnight
(16–18 h). Total plasma cholesterol was determined using an en-
zymatic assay (cholesterol kit 352-20; Sigma Diagnostics) accord-
ing to the manufacturer’s instructions. Cholesterol was separated
into very low density lipoprotein (VLDL), intermediate density
lipoprotein (IDL)/LDL, and high density lipoprotein (HDL) frac-
tions, subjecting 0.1 ml of plasma to fast performance liquid chro-
matography gel filtration on two Superose 6 columns (Pharmacia
Biotech Inc.) connected in series as described (30). 40 0.5-ml
fractions were collected, and cholesterol in each was determined
as above, with fractions 6–25 containing VLDL1IDL1LDL and
fractions 27–35 containing HDL.
Quantitation of Lesion Area. At 20 wk of age, the mice were
killed and their aortas isolated. Aortas were mounted and lesion
areas quantitated as described by a person blinded to the geno-
types (31). In brief, the cleaned aortas were cut open longitudi-
nally, pinned onto cardboard, and fixed in formalin. After stain-
ing with Oil Red O (Sigma Chemical Co.) and mounting on
glass slides, the aortas were scanned at high resolution with a
SprintScan 35 slide scanner (Polaroid). Lesion areas were then
calculated from the scanned images.
Histopathology. The aortas from three C57BL/6 wild-type,
three apo E2/2 with no CAM deficiency, three apo E2/2ICAM-
12/2, and three apo E2/2P-selectin2/2 animals were fixed in for-
malin, dehydrated through graded alcohol and xylene, and then
embedded in paraffin. Serial 5-mm-thick tissue sections were per-
formed, stained with hematoxylin and eosin, and evaluated mi-
croscopically in a blinded fashion for lesions. Representative pho-
tomicrographs were taken from each specimen for comparison
among the groups.
Statistical Analysis. Statistical analysis of the data generated
was conducted with Statview (version 4.5; Abacus Concepts,
Inc.) statistical analysis software. Two-way analysis of variance
(ANOVA) was used to determine the effects of genotype, gen-
der, and the interaction between genotype and gender. This anal-
ysis was completed for each of the independent CAM genes
tested.
Results
Production of Study Mice. With the starting mice all be-
ing backcrossed ($N6) and all study mice for each CAM
descended from the same grandparental breeding pair (Fig. 1),191 Collins et al. Brief Definitive Report
the mice used had minimal genetic variation apart from the
CAM genotype. Offspring of the breeding pairs, all apo E2/2
and 1/1, 1/2, or 2/2 for the CAM, were considered as
grouped littermates and were kept on the chow diet from
weaning until 20 wk of age before the aortas were harvested.
There was no difference in appearance or weight (data not
shown) of the males or females in any group.
Cholesterol Analysis. Total cholesterol levels were mea-
sured in all of the mice for the duration of the study to mon-
itor for possible differences in cholesterol levels (Table I). A
Kruskal-Wallis nonparametric ANOVA test indicated no dif-
ferences in total cholesterol or HDL cholesterol among an-
imals within each experimental group or at any time
point during the study. This was true in all groups for 4-wk
time points, CAM genotypes, and sexes of mice.
Lesion Analysis. Atherosclerotic lesions are more likely
to be observed in specific areas of the aorta. These include
the valve cusps, aortic arch, and the abdominal aorta in the
region of the renal arteries (Fig. 2). Smaller lesions includ-
ing fatty streaks were seen throughout the aorta but were
more common at arterial branch points. Cross-sections of
the most advanced lesions found in C57BL/6 wild-type,
apo E2/2 with no CAM deficiency, apo E2/2ICAM-12/2,
and apo E2/2P-selectin2/2 mice are shown in Fig. 3. The
calcification seen in the advanced lesions of apo E2/2 mice
was not observed in any of the aortas analyzed from ICAM-1
or P-selectin null mice. The most advanced lesions seen in
the P-selectin2/2 mice contained foam cells within ex-
panded intima.
There was very little size variation among the aortas due
to the consistent size of the mice. The area for atheroscle-
rotic lesions was determined, comparing the effect deficiency
for ICAM-1, P-selectin, and E-selectin in apo E2/2 mice,
with each gene defining an independent experimental group
of animals. Two-way ANOVA showed no significant inter-
action effect between genotype and gender (ICAM-1, P 5
0.81; P-selectin, P 5 0.33; and E-selectin, P 5 0.55); there-
fore, male and female lesion area data were combined for
calculation of statistical significance. As shown in Fig. 4, mice
homozygous null for the ICAM-1 mutation had significantly
less lesion formation than their ICAM-11/1 littermates
(4.08  6 0.70 mm2 for 2/2 males vs. 5.87 6 0.66 mm2 for
Figure 1. Breeding scheme for
generating study animals. All ani-
mals in the study were apo E2/2.
The animals for each CAM mu-
tation are all descendants of a sin-
gle founder pair of mice.
Table I. Plasma Cholesterol Levels in Study Mice
Genotype
Total
cholesterol
HDL
cholesterol
mg/dl 6 SD mg/dl 6 SD
apo E2/2CAM1/1 (n 5 50) 487 6 152 35 6 14
apo E2/2ICAM-12/2 (n 5 13) 471 6 123 41 6 17
apo E2/2P-selectin2/2 (n 5 19) 495 6 134 45 6 18
apo E2/2E-selectin2/2 (n 5 18) 503 6 139 39 6 15
Mice were fed a mouse chow diet from weaning until 20 wk of age,
and plasma cholesterol was determined as described in Materials and
Methods at 8, 12, 16, and 20 wk for all mice in the study (n 5 100).
There was no difference in cholesterol levels (Kruskal-Wallis nonpara-
metric ANOVA) for the time points or sexes within each experimental
group (CAM mutation), so they were combined. The amount of HDL
cholesterol was determined using fast performance liquid chromatogra-
phy for five mice in each group with no difference among groups.
There was also no significant difference in the cholesterol levels for any
experimental group of mice (Kruskal-Wallis).
Figure 2. Oil Red O–stained lesions on aortas from apo E2/2 mice. (A
and B) Representative aortas from P-selectin1/1 and ICAM-11/1 males,
respectively. Total lesion area on these aortas was 5.81 mm2 for A and
6.26 mm2 for B. Arrows point to more advanced lesions in the aortic
arch. (C and D) Aortas from two P-selectin2/2 males with total lesion ar-
eas of 3.08 and 2.91 mm2, respectively. Note the relative absence of le-
sions throughout the aorta compared with CAM1/1 mice in A and B. (E
and F) Aortas from ICAM-12/2 mice with lesion areas of 4.38 and 3.90
mm2, respectively. Early lesions are present in the aortic arch.192 Deficiency for P-Selectin or ICAM-1 Reduces Atherosclerosis
1/1 males, and 3.95 6 0.65 mm2 for 2/2 females vs.
5.59 6 1.13 mm2 for 1/1 females, combined P , 0.001).
Also shown in Fig. 4 is an even greater reduction of lesion
area in P-selectin2/2 mice (3.06 6 1.04 mm2 for 2/2
males vs. 5.09 6 1.22 mm2 for 1/1 males, and 2.85 6
1.26 mm2 for 2/2 females compared with 5.60 6 1.19
mm2 for 1/1 females, combined P , 0.001). Most of the
aortas from P-selectin2/2 mice were remarkably free of le-
sions except for the valve cusps. The reduction in lesion
area for E-selectin null mice, although less than that seen
for ICAM-1 or P-selectin, was still significant (4.54 6 2.14
mm2 for 2/2 males vs. 5.92 6 0.63 mm2 for 1/1 males,
and 4.38 6 0.85 mm2 for 2/2 females vs. 5.92 6 1.44
mm2 for 1/1 females, combined P , 0.01). None of the
mice heterozygous for CAM had differences in lesion areas
compared with apo E2/2 CAM1/1 mice (data not shown).
The lesion area data collected follows a normal distribution,
with significant protection from the development of ath-
erosclerosis observed in animals with null mutations in each
independent adhesion molecule.
Discussion
As reviewed in the Introduction, extensive studies have
demonstrated increased expression of leukocyte and endo-
thelial CAMs in atherosclerotic lesions, and genetic manip-
ulation has been used extensively in the mouse to study the
pathogenesis of atherosclerosis. In previous studies using a
high-fat diet containing cholic acid, individual CAM defi-
ciencies in C57BL/6 mice (17) and P-selectin or P- and
E-selectin deficiency in LDLR2/2 mice (18, 19), reduction
in lesion formation was observed. The studies presented
here demonstrate a reduction in atherosclerotic lesions us-
ing a more normal low-fat, low-cholesterol mouse chow
diet in the apo E2/2 mouse model. Importantly, the mice
were healthy, closely matched for genetic background and
husbandry, and showed no differences in plasma cholesterol.
The ICAM-12/2 mice demonstrated a 30% reduction in
lesions, and the P-selectin2/2 mice demonstrated a 45% re-
duction in lesions at 20 wk of age; the differences were
highly statistically significant for CAM2/2 compared with
Figure 3. Histopathologic com-
parison of aortas from study ani-
mals. Sections shown are typical
of the most advanced lesions
found in animals of each geno-
type. (A) C57BL/6 wild-type
murine aorta with intact intimal
(top), unremarkable media (mid-
dle), and adventitial (bottom)
layers with no evidence of ather-
omatous lesion. (B) Aorta from
apo E2/2 mouse with no CAM
deficiency showing well formed
atheromatous plaque character-
ized by foam cells, cell debris,
cholesterol clefts, and calcifica-
tion (arrow) within the expanded
intima. Lesions exhibiting the
calcification seen only in very
advanced lesions were only found
in apo E2/2 mice with no CAM
deficiency. (C) Aorta from an
apo E2/2ICAM-12/2 animal with
lesion composed of foam cells,
cholesterol clefts, and extracellu-
lar lipid in expanded intima (ar-
row). (D) Aorta from apo E2/2
P-selectin2/2 animal with less
developed atherosclerotic lesions (arrows) composed of frequent foam cells within expanded intima. Note relatively normal aortic segment between
atheromatous lesions. (All hematoxylin and eosin stain with original magnification of 200).
Figure 4. Effect of CAM deficiency on lesion area in apo E2/2 mice.
Each data point represents total lesion area (mm2) in an animal’s aorta be-
tween the aortic valve and the iliac branch for the sex and genotype
shown. Error bars represent mean 6 SD. Significant reduction in lesion
area was seen in the animals of each experimental group (CAM mutation)
with the P values shown. Along with the rigid control of genetics and
husbandry, two-way ANOVA indicated that the protection seen was due
to genotype, with no significant contribution from gender.193 Collins et al. Brief Definitive Report
CAM1/1 mice. Lesion reduction in E-selectin2/2 mice was
not as great, with 24% reduction in lesion area. Histopatho-
logical sections show that although foam cells are present in
P-selectin null mice and extracellular lipids and cholesterol
clefts occur in ICAM-1 null mice, the calcification seen in
the very advanced lesions of CAM1/1 mice were not found
in any of the mice lacking ICAM-1 or P-selectin. Studies of
this type can be carried out under many different circum-
stances, including transgenic expression of lipoprotein(a) or
cholesteryl ester transfer protein, various dietary conditions,
increased homocysteine levels, and genetic deficiency for
various CAMs and other inflammatory molecules. The stud-
ies reported here demonstrate that deficiency of P-selectin,
ICAM-1, or E-selectin provides substantial reduction in le-
sions in apo E2/2 mice fed a normal chow (low-fat) diet.
There is extensive evidence that monocytes play a piv-
otal role in the pathogenesis of atherosclerosis (2, 3, 14, 15).
Ligands for the three adhesion molecules examined in this
study are expressed on the surfaces of monocytes, and their
expression is upregulated upon monocyte activation (32). It
can be argued that leukocyte and endothelial CAMs play a
pivotal role in the pathogenesis of atherosclerosis, and that
the effects of many risk factors might be mediated through
effects on CAMs. Multiple reports demonstrate that ciga-
rette smoking promotes leukocyte and endothelial adhesion
reactions (33–35). There is also evidence to suggest that
hyperglycemia and diabetes mellitus might increase the ex-
pression of leukocyte and/or endothelial CAMs (36–38), and
shear stress selectively upregulates expression of ICAM-1
(39). Modified LDL can increase the expression of CAM
(40, 41), and the antiatherogenic effect of probucol may be
mediated by reducing the expression of VCAM-1, P-selec-
tin, and other inflammatory mediators (42). There is a pos-
itive association of soluble CAMs with carotid atherosclerosis
(43). Genetic polymorphisms in selectins may influence the
risk of atherosclerosis in humans (44, 45), and two reports
support the association of a serine®arginine mutation at
codon 128 of E-selectin with coronary artery disease (46, 47).
There is also a suggestion that lipoprotein Lp(a) may mediate
its proatherogenic effect through upregulation of VCAM-1
and E-selectin (48). It remains to be determined if strategies
to reduce the expression or adhesion of leukocyte and en-
dothelial CAMs can be used to achieve protection against
atherosclerosis in a clinical setting.
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